Brief: Ildong Pharmaceutical receives patent
July 13 (Reuters) - Ildong Pharmaceutical 000230.KS Co.,
Ltd.:
* Says it receives patent on July 13, for macromolecular
polysaccharide binder conjugated Lactobacillus rhamnosus
RHT-3201, and use thereof in prevention and treatment of atopic
dermatitis
Source text in Korean: http://me2.do/xcPO7w2z
Further company Coverage: 000230.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +861062674724;
Reuters Messaging: lima.jin.reuters.com@reuters.net))
Recent news on Ildong Holdings
See all newsBrief: Ildong Holdings To Divest 3.4 Billion Won Worth Of Own Shares
Brief: Ildong Holdings Q3 Operating Profit 6.5 Billion Won, Swings To Profit From Year Earlier
Brief: Ildong Holdings Q2 Operating Profit 335 Million Won, Swings To Profit From Year Earlier
Brief: Ildong Holdings Q1 Operating Profit 4 Billion Won, Swings To Profit From Year Earlier
Brief: Ildong Holdings Q4 Operating Profit 6.7 Billion Won, Swings To Profit From Year Earlier